Investors in Insulet Corp (Symbol: PODD) saw new options become available this week, for the August 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) in Q1 CY2025, with sales up 28.8% year on year to $569 million. On ...

TD Cowen has lifted its price target on Insulet Corporation (NASDAQ:PODD) to $379 from $324 while reiterating a Buy rating, pointing to strong early-year performance and recent executive changes that ...

Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy ...

Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains ...

Insulet (PODD) reported $569 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 28.8%. EPS of $1.02 for the same period compares to $0.73 a year ago.

Buying $100 In PODD: If an investor had bought $100 of PODD stock 15 years ago, it would be worth $2,028.81 today based on a ...

Insulet (PODD) reported $488.5 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 23.2%. EPS of $0.55 for the same period compares to $0.38 a year ago.